Kronox Lab Sciences Intrinsic Value
KRONOX Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹84.00 | ₹67.20 - ₹100.80 | -27.8% | EPS: ₹7.00, Sector P/E: 12x |
| Book Value Method | asset | ₹24.32 | ₹21.89 - ₹26.75 | -79.1% | Book Value/Share: ₹24.32, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹34.89 | ₹31.40 - ₹38.38 | -70.0% | Revenue/Share: ₹28.38, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹58.38 | ₹52.54 - ₹64.22 | -49.8% | EBITDA: ₹36.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹113.81 | ₹91.05 - ₹136.57 | -2.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹106.43 | ₹95.79 - ₹117.07 | -8.5% | EPS Growth: 19.0%, Fair P/E: 15.2x |
| Growth Adjusted P/E | growth | ₹57.70 | ₹51.93 - ₹63.47 | -50.4% | Revenue Growth: 6.1%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹112.43 | ₹101.19 - ₹123.67 | -3.3% | ROE: 28.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹48.65 | ₹43.78 - ₹53.52 | -58.2% | EPS: ₹7.00, BVPS: ₹24.32 |
Want to compare with current market value? Check KRONOX share price latest .
Valuation Comparison Chart
KRONOX Intrinsic Value Analysis
What is the intrinsic value of KRONOX?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Kronox Lab Sciences (KRONOX) is ₹58.38 (median value). With the current market price of ₹116.30, this represents a -49.8% variance from our estimated fair value.
The valuation range spans from ₹24.32 to ₹113.81, indicating ₹24.32 - ₹113.81.
Is KRONOX undervalued or overvalued?
Based on our multi-method analysis, Kronox Lab Sciences (KRONOX) appears to be trading above calculated value by approximately 49.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 28.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 32.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.06x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Kronox Lab Sciences
Additional stock information and data for KRONOX
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹31 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹17 Cr | ₹9 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹20 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |